Integrated pre-surgical diagnostic algorithm to define extent of disease in cervical cancer
Giulio Sozzi(University of Palermo), Vito Chiàntera(University of Palermo), Giovanni Scambia(Agostino Gemelli University Polyclinic), Domenico Messana(Azienda di Rilievo Nazionale ed Alta Specializzazione), Vincenzo Giallombardo(University of Palermo), Francesca Finazzo(Azienda di Rilievo Nazionale ed Alta Specializzazione), Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Marco Ferreri(University of Palermo), Stefania Fiengo(University of Campania "Luigi Vanvitelli"), Nicola Colacurci(University of Naples Federico II)
Cited by 9
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299